4.3 Pediatric Central Nervous System Infections

BCEN CPEN Certified Pediatric Emergency Nurse Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Triage Process & Initial Emergency Assessment

1.1 CPEN Exam Logistics, Blueprint & Certification Overview 1.2 Pediatric Triage Systems & Acuity Categorization 1.3 Pediatric Assessment Triangle (PAT) & Initial Impression 1.4 Primary & Secondary Pediatric Emergency Assessment 1.5 Age-Specific Vital Signs, Developmental Considerations & Pain Scales

2 Chapter 2: Pediatric Respiratory Emergencies

2.1 Upper Airway Obstruction 2.2 Lower Airway Emergencies 2.3 Respiratory Distress vs. Respiratory Failure & Airway Management

3 Chapter 3: Pediatric Cardiovascular Emergencies

3.1 Pediatric Dysrhythmias & ECG Analysis 3.2 Congenital Heart Defects 3.3 Acquired Heart Disease & Heart Failure

4 Chapter 4: Pediatric Neurological Emergencies

4.1 Pediatric Seizures, Status Epilepticus & Febrile Seizures 4.2 Altered Mental Status, Increased ICP & Head Trauma 4.3 Pediatric Central Nervous System Infections

5 Chapter 5: Pediatric Gastrointestinal & Genitourinary Emergencies

5.1 Pediatric GI Surgical Emergencies 5.2 Pediatric Dehydration, Gastroenteritis & Fluid Resuscitation Protocols 5.3 Pediatric GU & Renal Emergencies

6 Chapter 6: Pediatric Endocrine, Metabolic & Hematologic/Oncologic Emergencies

6.1 Diabetic Ketoacidosis (DKA) & Hypoglycemia in Pediatric Emergency Patients 6.2 Electrolyte Imbalances & Inborn Errors of Metabolism 6.3 Sickle Cell Disease Crisis & Pediatric Oncologic Emergencies

7 Chapter 7: Pediatric Musculoskeletal, Integumentary & ENT/Ophthalmic Emergencies

7.1 Pediatric Musculoskeletal Injuries & Fractures 7.2 Pediatric Dermatologic Emergencies & Rashes 7.3 Pediatric ENT & Ocular Emergencies

8 Chapter 8: Pediatric Trauma Emergencies

8.1 Pediatric Trauma Resuscitation & Anatomical Vulnerabilities 8.2 Head, Spinal & Thoracic Trauma in Children 8.3 Abdominal, Pelvic & Extremity Trauma in Pediatric Patients

9 Chapter 9: Child Maltreatment, Toxicology & Behavioral Emergencies

9.1 Child Abuse, Neglect, Non-Accidental Trauma & Mandatory Reporting 9.2 Pediatric Toxicology, Toxidromes & Emergency Antidotes 9.3 Pediatric Behavioral & Mental Health Crisis Management

10 Chapter 10: Pediatric Multi-System Emergencies, Shock & Thermal Injuries

10.1 Pediatric Shock Recognition & Classification 10.2 Pediatric Sepsis, Septic Shock & Multiple Organ Dysfunction Syndrome 10.3 Pediatric Anaphylaxis & Severe Allergic Reactions 10.4 Submersion Injuries, Drowning & Thermal/Burn Emergencies

11 Chapter 11: Professional Practice, Legal, Ethical & Safety Standards

11.1 Legal & Ethical Considerations 11.2 Patient Safety, Medication Error Prevention & Weight-Based Dosing 11.3 Family-Centered Care, Communication & Disaster/Surge Preparedness

4.3 Pediatric Central Nervous System Infections

Key Takeaways Explain This Topic AI

Neonatal bacterial meningitis (< 28 days) is primarily caused by Group B Streptococcus, E. coli, and Listeria monocytogenes, requiring empiric ampicillin plus cefotaxime.

Ceftriaxone is strictly contraindicated in neonates due to hyperbilirubinemia/kernicterus risk and biliary sludging/calcium precipitation.

Infants present with non-specific signs of meningitis (fever, paradoxical irritability, bulging fontanelle), whereas older children exhibit the classic triad of fever, nuchal rigidity, and altered LOC.

CSF in bacterial meningitis shows > 1,000 WBCs/mm³ with PMN predominance, low glucose (< 40% of serum), and elevated protein (> 100-500 mg/dL).

Empiric IV antibiotics must NEVER be delayed for head CT or lumbar puncture when bacterial meningitis is suspected.

Last updated: July 2026

4.3 Pediatric Central Nervous System Infections

Central nervous system (CNS) infections in pediatric patients—including bacterial meningitis, viral (aseptic) meningitis, and encephalitis—are life-threatening medical emergencies. Prompt recognition, rapid diagnostic differentiation, and immediate initiation of targeted antimicrobial therapy are critical to prevent mortality and long-term neurological sequelae such as sensorineural hearing loss, cognitive impairment, seizure disorders, and hydrocephalus.

Pathophysiology & Age-Specific Etiology

Infections of the CNS occur when pathogens breach the blood-brain barrier via hematogenous dissemination from mucosal colonization, direct extension from adjacent parameningeal structures (e.g., otitis media, sinusitis, mastoiditis), or direct inoculation following neurosurgery or penetrating head trauma.

Pathogens by Age Group

Neonates (< 28 Days) :

Group B Streptococcus ( Streptococcus agalactiae ): Most common neonatal pathogen, acquired vertically during vaginal delivery.

Escherichia coli (and other Gram-negative enteric bacilli such as Klebsiella ).

Listeria monocytogenes : Transmitted transplacentally or during birth; resistant to cephalosporins.

Infants & Children (> 28 Days to 17 Years) :

Streptococcus pneumoniae : Leading cause of bacterial meningitis in post-neonatal infants and children. Associated with severe neurological morbidity and sensorineural hearing loss.

Neisseria meningitidis : Encapsulated Gram-negative diplococcus responsible for epidemic outbreaks; causes severe fulminant meningococcemia.

Haemophilus influenzae type b (Hib) : Significantly reduced due to routine Hib conjugate vaccination, but remains a risk in unimmunized or under-immunized children.

Clinical Presentation & Physical Examination

Clinical manifestations vary significantly based on patient age and developmental stage.

Infants (< 12 Months)

Infants rarely present with classic meningeal signs due to unclosed cranial fontanelles and immature motor responses. Clinical presentation is often subtle and non-specific:

Fever or hypothermia (temperature instability)
Tense, bulging anterior fontanelle (best assessed while the infant is seated and quiet)

Paradoxical Irritability : The infant cries more intensely when held or rocked by parents due to positioning that stretches inflamed meninges.

Poor feeding, vomiting, lethargy, or high-pitched inconsolable cry
Hypotonia or focal seizure activity
Children & Adolescents (> 1 Year)

Presents with the classic diagnostic triad: Fever, Nuchal Rigidity, and Altered Mental Status .

Severe headache and intense photophobia

Nuchal Rigidity : Resistance and pain upon passive neck flexion.

Kernig's Sign : With the patient supine, flex the hip and knee to 90 degrees; resistance or severe pain upon subsequent passive extension of the knee indicates meningeal irritation.

Brudzinski's Sign : Involuntary flexion of the hips and knees when the patient's neck is passively flexed while supine. Kernig's Sign: Flex hip/knee 90° ──► Pain on knee extension ──► Positive

Brudzinski's Sign: Passive neck flexion ──► Involuntary hip/knee flexion ──► Positive
Meningococcemia & Purpura Fulminans

Infection with Neisseria meningitidis can produce a fulminant systemic vasculitis:

Initial petechial rash rapidly coalesces into ecchymotic, purpuric lesions ( purpura fulminans ).

Triggers disseminated intravascular coagulation (DIC), profound septic shock, and bilateral adrenal hemorrhage ( Waterhouse-Friderichsen syndrome ).

Emergency Isolation : Instigate immediate Droplet Precautions (mask, eye protection, gloves) in addition to Standard Precautions upon suspicion of meningococcal disease.

Lumbar Puncture (LP) & CSF Analysis

Diagnostic evaluation requires lumbar puncture for cerebrospinal fluid (CSF) analysis, unless contraindications are present.

Cerebrospinal Fluid (CSF) Differentiating Profile

CSF Parameter Normal Range Bacterial Meningitis Viral (Aseptic) Meningitis Fungal / TB Meningitis
Opening Pressure 50-180 mm H2O Markedly Elevated (> 200) Normal to Slightly Elevated Elevated
WBC Count (/mm³) 0-5 (Neonate 0-20) > 1,000 (often 5,000-10,000) 10 to 500 100 to 500
Predominant Cell Mononuclear PMNs / Neutrophils (> 80%) Lymphocytes Lymphocytes
CSF Glucose 40-70 mg/dL Markedly Low (< 40 mg/dL) Normal (> 45 mg/dL) Low (< 40 mg/dL)
CSF/Serum Glucose Ratio > 0.6 (60%) Low (< 0.4 or < 40%) Normal (> 0.6) Low (< 0.4)
Protein 15-45 mg/dL Markedly High (> 100-500) Normal to Mild High (50-100) High (> 100-500)
Appearance Clear, colorless Turbid, cloudy, purulent Clear or slightly hazy Fibrinous / Web-like
Contraindications to Immediate Lumbar Puncture

Signs of Increased ICP or Impending Brainstem Herniation : Focal neurological deficits, papilledema, pGCS ≤ 8, Cushing's triad, unreactive/asymmetric pupils.

Severe Hemodynamic Instability or Septic Shock : LP positioning (flexed lateral decubitus) compromises airway and venous return.

Severe Thrombocytopenia or Coagulopathy : Risk of epidural hematoma and spinal cord compression.

Infection at the LP Insertion Site : Risk of introducing bacteria into the subarachnoid space.

Critical Rule : If LP is delayed for neuroimaging (Head CT) or due to clinical instability, NEVER DELAY ANTIMICROBIAL THERAPY . Administer empiric IV antibiotics and blood cultures immediately before sending the patient for CT.

Age-Specific Antimicrobial Coverage & Adjunctive Therapy

Empiric antimicrobial selection must cover age-specific bacterial pathogens and breach the blood-brain barrier at meningeal therapeutic concentrations.

Empiric Regimens by Age Group

Neonates (< 28 Days) :

Ampicillin (100 mg/kg IV q6h) PLUS Cefotaxime (50 mg/kg IV q6h) OR Gentamicin (2.5 mg/kg IV q8h).

Rationale : Ampicillin provides essential coverage against Listeria monocytogenes and Group B Streptococcus. Cefotaxime covers Gram-negative enterics ( E. coli ).

Avoid Ceftriaxone in Neonates : Ceftriaxone is contraindicated in neonates because it displaces bilirubin from albumin, increasing the risk of kernicterus , and precipitates with intravenous calcium-containing solutions (biliary sludging).

Infants & Children (> 28 Days to 17 Years) :

Vancomycin (15-20 mg/kg IV q6h) PLUS Ceftriaxone (50 mg/kg IV q12h; max 2 g/dose) OR Cefotaxime (75 mg/kg IV q6h).

Rationale : High-dose Ceftriaxone/Cefotaxime treats N. meningitidis and sensitive S. pneumoniae . Vancomycin is added to cover ceftriaxone-resistant Streptococcus pneumoniae strains.

Adjunctive Dexamethasone Therapy

Administer Dexamethasone 0.15 mg/kg IV q6h for 4 days in infants and children > 6 weeks of age with suspected or confirmed Hib or S. pneumoniae meningitis.

Timing : Must be administered prior to or concurrently with the first dose of IV antibiotics. Dexamethasone inhibits inflammatory cytokine release triggered by antibiotic-induced bacterial lysis, significantly reducing the incidence of sensorineural hearing loss .

Empirical Acyclovir for Encephalitis

Add Acyclovir 20 mg/kg IV q8h in neonates or children presenting with signs of encephalitis (focal seizures, temporal lobe involvement on EEG/MRI, vesicles, or severe lethargy) to treat suspected Herpes Simplex Virus (HSV-1 or HSV-2) encephalitis.

Encephalitis vs. Meningitis

Unlike meningitis (inflammation restricted to the meninges), encephalitis involves inflammation of the brain parenchyma itself.

Clinical Hallmarks : Prominent altered mental status, personality/behavioral changes, acute psychosis, focal neurological deficits (hemiparesis, cranial nerve palsies), and focal motor seizures.

Etiology : Primarily viral (HSV-1, Enteroviruses, Arboviruses, EBV).

Diagnosis : CSF PCR for viral DNA/RNA, EEG (showing temporal lobe periodic sharp wave complexes characteristic of HSV), and brain MRI.

Clinical Scenario

A 3-month-old infant is brought to the ED with a 2-day history of fever (39.1°C), poor feeding, and extreme irritability. Physical exam reveals a tense, bulging anterior fontanelle and paradoxical irritability when held by the mother. Blood cultures are drawn. Before lumbar puncture is performed, the infant exhibits a brief 45-second focal seizure. The emergency nurse immediately establishes IV access, administers empiric IV Vancomycin (20 mg/kg), Ceftriaxone (50 mg/kg), and Dexamethasone (0.15 mg/kg), and prepares the infant for a non-contrast head CT to rule out mass effect prior to performing the LP.